# Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant

> **NCT05766332** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 137 (actual)

## Conditions studied

- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **OTHER:** Clinical Evaluation
- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT05766332
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-02
- **Primary completion:** 2023-11-17
- **Final completion:** 2023-11-17
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05766332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05766332, "Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05766332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*